Quick Takeaways
- David Capital Partners, LLC filed SCHEDULE 13G/A for LIFECORE BIOMEDICAL, INC. \DE\ Common Stock, par value $0.001 (LFCR).
- Disclosed ownership: 4.9%.
- Date of event: 31 Dec 2024.
David Capital Partners, LLC - 31 Dec 2024 SCHEDULE 13G/A Report for LIFECORE BIOMEDICAL, INC. \DE\ Common Stock, par value $0.001 (LFCR)
- Filing Manager
- David Capital Partners, LLC
- Reporting Manager
- David Capital Partners, LLC
- Symbol
- LFCR
- Shares outstanding
- 37,022,587 shares
- Disclosed Ownership
- 1,803,000 shares
- Ownership
- 4.9%
- Form type
- SCHEDULE 13G/A
- Filing time
- 05 Feb 2025, 15:24:45 UTC
- Date of event
- 31 Dec 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"David Capital Partners, LLC disclosed 4.9% ownership in LIFECORE BIOMEDICAL, INC. \DE\ Common Stock, par value $0.001 (LFCR) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 05 Feb 2025, 15:24.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| David Capital Partners, LLC | 4.9% | 1,803,000 | 1,803,000 | 0 | Adam J. Patinkin | Managing Member | |
| David Capital Partners Fund, LP | 4.9% | 1,803,000 | 1,803,000 | 0 | Adam J. Patinkin | Managing Member of David Capital Partners, LLC, the |